Posts by Admin BioAlps

In-house expertise, strategic partnerships and collaboration   The following article is part of BioAlps’ testimonial series and was written by Mrs Sandra Ruckstuhl, Head of Europe Manufacturing Sites Communications at CSL Behring. Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are active in finding and developing…

SOPHiA GENETICS and Dasa foster a new data-driven medicine era in the fight against cancer   On 23 July, SOPHiA GENETICS, leader in Data-Driven Medicine, announced the signature of a Trial Match agreement with Dasa, the largest medical diagnostic company in Latin America. The group chose the SOPHiA Platform to lead the region toward an…

New MRI method, developed in Lausanne enhances eye imagery and clears new path for further research   Research from the Lausanne University Hospital (CHUV), the University of Lausanne and the Lausanne Ophthalmic Hospital Jules-Gonin, published in the Progress in Neurobiology review, details a new MRI method which enables the capture of simultaneous details about the…

Incyte inaugurates its new European HQ in Morges   In July 2020, the global pharmaceutical company, Incyte inaugurated its new production site and European headquarters, with the support of Innovaud,  in Morges in the canton of Vaud. The site will welcome 150 employees from the company’s regional and international branches which focus on regulation, clinical…

Artiria Medical raises CHF 3 million to improve stroke treatment   EPFL spin-off, Artiria Medical, is developing micro-actuated catheters and guidewires enabling surgeons to navigate quickly but surely through cerebral arteries. The startup raised CHF 3 million series A from Swiss investors such as 4FO Venture Partners, investiere, Zürcher Kantonal Bank (ZKB), Venture Kick, NEST…

iOnctura raise an additional €5.1 million for their series A funding, reaching a total of €20.1 million   The Geneva-based startup, iOnctura, focuses on clinical stage biopharmaceutical development of different next-generation molecules targeting cancer fibrosis. The startup announced on 14 July 2020 raising another €5.1 million euros from a new investor 3B Future Health Fund,…

EMBION™ Technologies S.A., hard-tech, disruptive innovator in plant-based bioactives for the nutrition of the future, announces the market launch of PREMBION™. It is the first patented product with complex prebiotic properties for animal nutrition that was created with EMBION’s novel platform technology. The spin-off of the Swiss Federal Institute of Technology in Lausanne (EPFL) accelerates nutrition innovation toward increased functionality and greater affordability. It reduces the time from discovery to commercial production by up to 80%. Market introduction tests are currently underway with leading global corporations in the food, feed and drinks sectors.

CoreMedica Europe | A blood test to screen your immune system   The Geneva-based startup has entered the COVID-19 diagnostics race with its own blood test kit. In a record time, CoreMedica Europe has developed and launched on the Swiss market a blood test enabling a full immune system check-up. 3 drops of blood collected…

Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies   On 25 June 2020, Polares Medical SA, a clinical stage medical technology company focused on the development of a unique trans-catheter mitral valve hemi-replacement system to treat patients suffering from mitral regurgitation (MR), announced the closing of a $40 million financing led by…

Unique biosafety laboratory at the University of Bern   On 16 June, the new BSL-3 biosafety laboratory of the University of Bern Institute of Infectious Diseases (IFIK) became operational. The laboratory, based at sitem-insel, is nationally one of the largest and the only BSL-3 laboratory in Switzerland to combine diagnostics, research and translation under one…